PortalPublikationenTreatment trends and Medicare reimbursements for localized p...

Treatment trends and Medicare reimbursements for localized prostate cancer in elderly patients

Standard

Treatment trends and Medicare reimbursements for localized prostate cancer in elderly patients. / Dell'oglio, Paolo; Valiquette, Anne Sophie; Leyh-Bannurah, Sami-Ramzi; Tian, Zhe; Trudeau, Vincent; Larcher, Alessandro; Shariat, Shahrokh F; Capitanio, Umberto; Briganti, Alberto; Graefen, Markus; Montorsi, Francesco; Karakiewicz, Pierre I.

in: CUAJ-CAN UROL ASSOC, Jahrgang 12, Nr. 7, 07.2018, S. E338-E344.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Dell'oglio, P, Valiquette, AS, Leyh-Bannurah, S-R, Tian, Z, Trudeau, V, Larcher, A, Shariat, SF, Capitanio, U, Briganti, A, Graefen, M, Montorsi, F & Karakiewicz, PI 2018, 'Treatment trends and Medicare reimbursements for localized prostate cancer in elderly patients', CUAJ-CAN UROL ASSOC, Jg. 12, Nr. 7, S. E338-E344. https://doi.org/10.5489/cuaj.4865

APA

Dell'oglio, P., Valiquette, A. S., Leyh-Bannurah, S-R., Tian, Z., Trudeau, V., Larcher, A., Shariat, S. F., Capitanio, U., Briganti, A., Graefen, M., Montorsi, F., & Karakiewicz, P. I. (2018). Treatment trends and Medicare reimbursements for localized prostate cancer in elderly patients. CUAJ-CAN UROL ASSOC, 12(7), E338-E344. https://doi.org/10.5489/cuaj.4865

Vancouver

Dell'oglio P, Valiquette AS, Leyh-Bannurah S-R, Tian Z, Trudeau V, Larcher A et al. Treatment trends and Medicare reimbursements for localized prostate cancer in elderly patients. CUAJ-CAN UROL ASSOC. 2018 Jul;12(7):E338-E344. https://doi.org/10.5489/cuaj.4865

Bibtex

@article{34a5b5e1df954f068d8c2054e4920906,
title = "Treatment trends and Medicare reimbursements for localized prostate cancer in elderly patients",
abstract = "INTRODUCTION: The absolute and proportional numbers of elderly patients diagnosed with localized prostate cancer (PCa) are on the rise. We examined treatment trends and reimbursement figures in localized PCa patients aged ≥80 years.METHODS: Between 2000 and 2008, we identified 30 217 localized PCa patients aged ≥80 years in Surveillance, Epidemiology, and End Results (SEER)-Medicare-linked database. Alternative treatment modalities consisted of conservative management (CM), radiation therapy (RT), radical prostatectomy (RP), and primary androgen-deprivation therapy (PADT). For all four modalities, utilization and reimbursements were examined.RESULTS: PADT was the most frequently used treatment modality between 2000 and 2005. CM became the dominant treatment modality from 2006-2008. RP rates were marginal. RT ranked third, and its annual rate increased from 20.77% in 2000 to 29.13% in 2008. Median individual reimbursement of RT was highest and ranged from $29 343 in 2000 to $31 090 in 2008, followed by RP (from $20 560 in 2000 to $19 580 in 2008), PADT (from $18 901 in 2000 to $8000 in 2008), and CM (from $1824 in 2000 to $1938 in 2008). RT contributed to most of the cumulative annual reimbursements from 2003 (49.24%) to 2008 (72.97%). PADT ranked first from 2000 (54.56%) to 2002 (50.49%), but decreased by 19.40% in 2008. CM's contribution increased from 4.42% in 2000 to 6.96% in 2008. RP's share of reimbursements was stable during the study period.CONCLUSIONS: Our results, focusing on localized PCa treatment in patients aged ≥80 years, showed an important increase in rates, median cost, and proportion of cumulative cost related to RT.",
keywords = "Journal Article",
author = "Paolo Dell'oglio and Valiquette, {Anne Sophie} and Sami-Ramzi Leyh-Bannurah and Zhe Tian and Vincent Trudeau and Alessandro Larcher and Shariat, {Shahrokh F} and Umberto Capitanio and Alberto Briganti and Markus Graefen and Francesco Montorsi and Karakiewicz, {Pierre I}",
year = "2018",
month = jul,
doi = "10.5489/cuaj.4865",
language = "English",
volume = "12",
pages = "E338--E344",
journal = "CUAJ-CAN UROL ASSOC",
issn = "1911-6470",
publisher = "Canadian Medical Association",
number = "7",

}

RIS

TY - JOUR

T1 - Treatment trends and Medicare reimbursements for localized prostate cancer in elderly patients

AU - Dell'oglio, Paolo

AU - Valiquette, Anne Sophie

AU - Leyh-Bannurah, Sami-Ramzi

AU - Tian, Zhe

AU - Trudeau, Vincent

AU - Larcher, Alessandro

AU - Shariat, Shahrokh F

AU - Capitanio, Umberto

AU - Briganti, Alberto

AU - Graefen, Markus

AU - Montorsi, Francesco

AU - Karakiewicz, Pierre I

PY - 2018/7

Y1 - 2018/7

N2 - INTRODUCTION: The absolute and proportional numbers of elderly patients diagnosed with localized prostate cancer (PCa) are on the rise. We examined treatment trends and reimbursement figures in localized PCa patients aged ≥80 years.METHODS: Between 2000 and 2008, we identified 30 217 localized PCa patients aged ≥80 years in Surveillance, Epidemiology, and End Results (SEER)-Medicare-linked database. Alternative treatment modalities consisted of conservative management (CM), radiation therapy (RT), radical prostatectomy (RP), and primary androgen-deprivation therapy (PADT). For all four modalities, utilization and reimbursements were examined.RESULTS: PADT was the most frequently used treatment modality between 2000 and 2005. CM became the dominant treatment modality from 2006-2008. RP rates were marginal. RT ranked third, and its annual rate increased from 20.77% in 2000 to 29.13% in 2008. Median individual reimbursement of RT was highest and ranged from $29 343 in 2000 to $31 090 in 2008, followed by RP (from $20 560 in 2000 to $19 580 in 2008), PADT (from $18 901 in 2000 to $8000 in 2008), and CM (from $1824 in 2000 to $1938 in 2008). RT contributed to most of the cumulative annual reimbursements from 2003 (49.24%) to 2008 (72.97%). PADT ranked first from 2000 (54.56%) to 2002 (50.49%), but decreased by 19.40% in 2008. CM's contribution increased from 4.42% in 2000 to 6.96% in 2008. RP's share of reimbursements was stable during the study period.CONCLUSIONS: Our results, focusing on localized PCa treatment in patients aged ≥80 years, showed an important increase in rates, median cost, and proportion of cumulative cost related to RT.

AB - INTRODUCTION: The absolute and proportional numbers of elderly patients diagnosed with localized prostate cancer (PCa) are on the rise. We examined treatment trends and reimbursement figures in localized PCa patients aged ≥80 years.METHODS: Between 2000 and 2008, we identified 30 217 localized PCa patients aged ≥80 years in Surveillance, Epidemiology, and End Results (SEER)-Medicare-linked database. Alternative treatment modalities consisted of conservative management (CM), radiation therapy (RT), radical prostatectomy (RP), and primary androgen-deprivation therapy (PADT). For all four modalities, utilization and reimbursements were examined.RESULTS: PADT was the most frequently used treatment modality between 2000 and 2005. CM became the dominant treatment modality from 2006-2008. RP rates were marginal. RT ranked third, and its annual rate increased from 20.77% in 2000 to 29.13% in 2008. Median individual reimbursement of RT was highest and ranged from $29 343 in 2000 to $31 090 in 2008, followed by RP (from $20 560 in 2000 to $19 580 in 2008), PADT (from $18 901 in 2000 to $8000 in 2008), and CM (from $1824 in 2000 to $1938 in 2008). RT contributed to most of the cumulative annual reimbursements from 2003 (49.24%) to 2008 (72.97%). PADT ranked first from 2000 (54.56%) to 2002 (50.49%), but decreased by 19.40% in 2008. CM's contribution increased from 4.42% in 2000 to 6.96% in 2008. RP's share of reimbursements was stable during the study period.CONCLUSIONS: Our results, focusing on localized PCa treatment in patients aged ≥80 years, showed an important increase in rates, median cost, and proportion of cumulative cost related to RT.

KW - Journal Article

U2 - 10.5489/cuaj.4865

DO - 10.5489/cuaj.4865

M3 - SCORING: Journal article

C2 - 29603911

VL - 12

SP - E338-E344

JO - CUAJ-CAN UROL ASSOC

JF - CUAJ-CAN UROL ASSOC

SN - 1911-6470

IS - 7

ER -